Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $4.58B | $162.04 | $185.67 | 14.58% | Strong Buy | 6 | 104.18% | 52.91% | N/A | N/A | ||||
| TGTX | TG THERAPEUTICS INC | $2.20B | $14.25 | $30.20 | 111.93% | Strong Buy | 5 | 38.43% | 139.09% | N/A | N/A | ||||
| GMAB | GENMAB A | $18.87B | $28.56 | $45.00 | 57.56% | Buy | 4 | 21.76% | 48.09% | N/A | N/A | ||||
| INCY | INCYTE CORP | $11.60B | $51.65 | $73.92 | 43.11% | Buy | 12 | 11.49% | 52.77% | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $17.37B | $92.06 | $103.44 | 12.37% | Strong Buy | 9 | 12.22% | 94.71% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.64B | $28.85 | $37.33 | 29.40% | Buy | 6 | 17.13% | 42.05% | N/A | N/A | ||||
| CORT | CORCEPT THERAPEUTICS INC | $2.38B | $23.00 | $39.33 | 71.01% | Strong Buy | 3 | 16.94% | 29.98% | N/A | N/A | ||||
| MDXG | MIMEDX GROUP INC | $956.70M | $6.51 | $12.67 | 94.58% | Strong Buy | 3 | 11.82% | 25.46% | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $4.94B | $38.97 | $54.17 | 39.00% | Buy | 6 | 15.99% | 48.53% | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $16.62B | $27.82 | $46.75 | 68.04% | Strong Buy | 4 | 11.31% | 34.87% | N/A | N/A | ||||
| VNDA | VANDA PHARMACEUTICALS INC | $266.40M | $4.63 | N/A | N/A | N/A | N/A | 13.15% | 102.06% | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $10.01B | $63.69 | $78.43 | 23.14% | Strong Buy | 7 | 6.67% | 29.33% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $7.06B | $23.29 | $27.17 | 16.65% | Buy | 6 | 8.37% | 55.63% | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.84B | $109.67 | $193.09 | 76.07% | Strong Buy | 11 | 6.52% | 64.32% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $247.30M | $5.13 | $7.00 | 36.45% | Buy | 1 | 0.26% | 31.88% | N/A | N/A | ||||
| BNTX | BIONTECH SE | $21.04B | $88.49 | $114.71 | 29.63% | Hold | 7 | -10.83% | 36.84% | N/A | N/A | ||||
| AMLX | AMYLYX PHARMACEUTICALS INC | $132.18M | $1.95 | $11.00 | 464.10% | Buy | 5 | -49.09% | 142.34% | N/A | N/A | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.74B | $14.73 | $27.40 | 86.01% | Strong Buy | 5 | 16.34% | 16.52% | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $580.17B | $128.64 | $133.00 | 3.39% | Strong Buy | 6 | 20.70% | 4.76% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $11.03B | $234.47 | $298.00 | 27.10% | Strong Buy | 7 | 9.49% | 8.78% | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $99.59B | $907.32 | $1.00k | 10.50% | Buy | 16 | 7.40% | 4.84% | N/A | N/A | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | $104.59B | $404.91 | $451.75 | 11.57% | Buy | 16 | 8.93% | 2.45% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.